Hematology Diagnostic Market Ascending to a Projected US$ 2.0 Billion Valuation by 2033-FMI Study

The Haematology Diagnostics Market is expected to be worth US$ 780.0 million in 2023 and US$ 2.0 billion by 2033. During the forecast period, the market for haematology diagnostics is expected to grow at a CAGR of 9.9%.

Cancer, blood clots, blood-related disorders, and infections are driving market expansion. Furthermore, the use of artificial intelligence and increasing advanced technology to aid in faster diagnosis are driving haematology diagnostics market opportunities.

The rising prevalence of blood disorders such as anaemia, thalassemia, and sickle cell disease is driving market opportunities. Furthermore, R&D activities, advanced devices to provide accurate clinical decisions, and new market players are increasing haematology diagnostics sales. Furthermore, the advancement of standardised diagnostics with increased efficiency to

The innovation of non-invasive hematology equipment and point-of-care diagnostics is boosting the market growth. According to a study published in 2019, India ranks third after the United States and China, in blood cancer.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9046

Manufacturers Increased Automation in Hematology Diagnostics to Surge Market Opportunities 

The growing advanced technology in the medical field is uplifting the healthcare sector in recent years. The manufacturers are experimenting with various medical devices to provide accurate results, better responses, and reduce check-up time.

These manufacturers are launching innovative devices that meet patients’ requirements during the forecast period. In addition, launching automatic and advanced equipment with artificial intelligence to record patient data, disease, and personal data are growing market opportunities.

Key Takeaways:

• The hematology diagnostics market is expected to reach US$ 2.0 billion by 2033.
• The global market is expected to register a CAGR of 9.9% during the forecast period.
• The market in the United States hematology diagnostics record a CAGR of 9.7% through 2033.
• With a CAGR of 8.9%, the United Kingdom market significantly uplifts during the forecast period.
• The China market is expected to record a CAGR of 9.3% over the forecast period.

Who is Winning?

The prominent players fragment the market during the forecast period. Therefore, marketers are using various strategies to propel market growth.

• Developing Innovative Products: The manufacturers and top companies focus on developing devices based on machine learning (ML) and deep learning (DL) methods for hematology diagnostics patients.
• Increasing Distribution Channels: The key companies are launching their products to acquire massive revenue in the global market. These companies provide their goods and services through multiple distribution channels such as retail, wholesale, supermarkets, and online.
• Trustworthy Brand: The manufacturing companies are developing advanced and transparent brands for their customers. The manufacturers are aware of sustainable products that maintain a trustworthy relationship between the buyer and seller.

Other Prominent Players in the Market are:

•  Meyland Smith A/S
• Abbot Laboratories
• Bio-Rad Laboratories
• Sysmex Corporation
• Mindray Medical International Limited
• Siemens Healthlineers
• F. Hoffman-La Roche Ltd.
• HORIBA Ltd.
• HemoCue AB
• Danaher (Beckman Coulter Inc.)
• Nihon Kohden Corporation
• EKF Diagnostics
• Ortho Clinical Diagnostics
• Drew Scientific

Recent Development 

• In Oct 2021, Suburban Diagnostics announced its newly launched Centre of Excellence for hematology diagnostics patients. The freshly launched find out various common and uncommon disorders by providing training and research support.
• In Apr 2022, A medical device company, Sysmex Corporation, launched its new systems, including XQ-Series and XQ-320 Series. These are the automated system that provides multi-feature requirement in the laboratories.
• In Mar 2022, Mindray launched the BC-700 series. These series incorporate complete blood count and erythrocyte sedimentation tests.

Tailored Perspectives Await: Craft Your Personalized Report Experience Now :
https://www.futuremarketinsights.com/customization-available/rep-gb-9046

Hematology Diagnostics Market by Category

By Kit Type:

• Anemia and Iron Test Kits
• Folic Acid Testing Kits
• Sickle Cell Screening Kits
• PT/INR Testing Kits
• D-dimer Testing Kits
• Blood Typing Kits
• Leukemia Testing Kits
• Sepsis Testing Kits
• Antibiotics Resistance Panels
• Bacterial & Fungal Panels

By Modality:

• Point of Care
• Lab-based Testing

By Distribution Channel:

• Hospitals
• Diagnostic Laboratories
• Cancer Research Institutes
• Retail Pharmacies
• Drug Store
• Online Sales Channels

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube